From Medical Empire to Winter: Revelations of Japan's 30-Year Healthcare Reform

Abstract

During its economic boom in the 1990s, Japan established a government-subsidized medical security system, a model that proved unsustainable amid a rapidly shifting population structure. Faced with the dual pressures of economic transformation and an aging society, the Japanese government was compelled to re-examine its medical policy, shifting its focus from the expansion and enhancement of medical services to the control of costs in order to maintain the sustainability of the health insurance system. This reform established a tightly controlled closed-loop system defined by government pricing, hospital implementation, and pharmaceutical supply. Within this framework, pharmaceutical companies bore the brunt of the policy’s financial burden. The eventual outcome was a fiscal surplus achieved at the expense of significant regression in both the pharmaceutical industry and medical services. Japan’s thirty-year medical reform demonstrates that system design must fully account for the interests and demands of all stakeholders and establish a mechanism for dynamic equilibrium to ensure sustainable development. A thorough examination of Japan’s reform experience and lessons, in light of China’s own national conditions, holds considerable relevance for China today.